Female patient talking to doctor. There was no significant difference in event-free survival between the carboplatin-containing arms. Adding carboplatin to neoadjuvant paclitaxel significantly ...

Adjuvant carboplatin added to standard anthracycline/taxane chemotherapy significantly improves outcomes in early ...

Phase II window of irinotecan plus carboplatin in newly diagnosed patients with rhabdomyosarcoma: Results of Memorial Sloan-Kettering Cancer Center (MSKCC) Protocol IRB 03-099. Background: The ...

New York, NY (August 20, 2025) – A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin ...

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based ...

NEW YORK-- A nationwide chemotherapy drug shortage is impacting cancer patients and doctors in New York. "We're really in an unprecedented situation in the cancer field," said Dr. Richard Carvajal, a ...

Elizabeth Arnold was diagnosed with advanced uterine cancer a month and a half ago. “People ask me if I'm depressed, and I say, ‘No, I'm not depressed. I'm just terrified.’ You know, your whole world ...

The addition of olaparib to neoadjuvant chemotherapy improved overall survival in BRCA-mutated breast cancer, despite no improvement in pathologic response. Adding the PARP inhibitor led to a 3-year ...

CHARLOTTE, N.C. – Common cancer drugs are running short due to ongoing supply chain issues, forcing doctors to make tough decisions about treating patients., a new survey shows The National ...